Eisai Co., Ltd. (4523.T)
JPY 4338.0
(-0.28%)
JPY 4338.0
(-0.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 103.1 Billion JPY | -1.27% |
| 2022 | 87.25 Billion JPY | -7.71% |
| 2021 | 94.55 Billion JPY | 4.81% |
| 2020 | 90.04 Billion JPY | -44.73% |
| 2019 | 162.93 Billion JPY | 38.5% |
| 2018 | 117.75 Billion JPY | 11.23% |
| 2017 | 105.81 Billion JPY | 21.23% |
| 2016 | 86.92 Billion JPY | -0.71% |
| 2015 | 87.99 Billion JPY | 26.27% |
| 2014 | 69.56 Billion JPY | -41.55% |
| 2013 | 93.35 Billion JPY | -4.84% |
| 2012 | 129.2 Billion JPY | -13.94% |
| 2011 | 150.23 Billion JPY | -11.14% |
| 2010 | 161.25 Billion JPY | 13.24% |
| 2009 | 139.3 Billion JPY | -2.77% |
| 2008 | 136.74 Billion JPY | 175.87% |
| 2007 | 52.81 Billion JPY | -60.71% |
| 2006 | 137.2 Billion JPY | 9.79% |
| 2005 | 121.14 Billion JPY | 12.1% |
| 2004 | 110.06 Billion JPY | 9.5% |
| 2003 | 101.89 Billion JPY | 20.99% |
| 2002 | 87.84 Billion JPY | -8.2% |
| 2001 | 91.74 Billion JPY | 61.59% |
| 2000 | 58.52 Billion JPY | 35.81% |
| 1999 | 41.8 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 23.47 Billion JPY | -7.64% |
| 2023 Q2 | 17.75 Billion JPY | -53.98% |
| 2023 FY | - JPY | -1.27% |
| 2023 Q4 | 16.44 Billion JPY | -10.28% |
| 2023 Q3 | 18.32 Billion JPY | 3.25% |
| 2023 Q1 | 38.57 Billion JPY | 0.58% |
| 2022 FY | - JPY | -7.71% |
| 2022 Q2 | 8.75 Billion JPY | -56.1% |
| 2022 Q3 | 20.22 Billion JPY | 131.15% |
| 2022 Q4 | 38.34 Billion JPY | 89.58% |
| 2022 Q1 | 19.93 Billion JPY | 280.14% |
| 2021 FY | - JPY | 4.81% |
| 2021 Q2 | 15.81 Billion JPY | -75.9% |
| 2021 Q1 | 65.61 Billion JPY | 1502.25% |
| 2021 Q3 | 24.18 Billion JPY | 52.93% |
| 2021 Q4 | -11.06 Billion JPY | -145.75% |
| 2020 Q1 | 41.45 Billion JPY | -32.46% |
| 2020 FY | - JPY | -44.73% |
| 2020 Q2 | 11.27 Billion JPY | -72.81% |
| 2020 Q4 | 4.09 Billion JPY | -87.74% |
| 2020 Q3 | 33.39 Billion JPY | 196.27% |
| 2019 Q3 | 51 Billion JPY | 233.12% |
| 2019 FY | - JPY | 38.5% |
| 2019 Q1 | 35.53 Billion JPY | -3.81% |
| 2019 Q4 | 61.37 Billion JPY | 20.34% |
| 2019 Q2 | 15.31 Billion JPY | -56.92% |
| 2018 Q4 | 36.94 Billion JPY | 123.33% |
| 2018 Q2 | 35.66 Billion JPY | 24.28% |
| 2018 Q1 | 28.69 Billion JPY | -24.15% |
| 2018 Q3 | 16.54 Billion JPY | -53.62% |
| 2018 FY | - JPY | 11.23% |
| 2017 FY | - JPY | 21.23% |
| 2017 Q3 | 26.32 Billion JPY | 34.98% |
| 2017 Q2 | 19.5 Billion JPY | -12.47% |
| 2017 Q1 | 22.28 Billion JPY | 169.87% |
| 2017 Q4 | 37.83 Billion JPY | 43.71% |
| 2016 Q2 | 18.88 Billion JPY | -45.18% |
| 2016 FY | - JPY | -0.71% |
| 2016 Q3 | 25.79 Billion JPY | 36.55% |
| 2016 Q1 | 34.45 Billion JPY | 234.23% |
| 2016 Q4 | 8.25 Billion JPY | -67.99% |
| 2015 Q1 | 18.61 Billion JPY | 17.49% |
| 2015 Q2 | 20.92 Billion JPY | 12.41% |
| 2015 Q4 | 10.3 Billion JPY | -72.99% |
| 2015 Q3 | 38.17 Billion JPY | 82.41% |
| 2015 FY | - JPY | 26.27% |
| 2014 Q1 | 18.37 Billion JPY | -53.18% |
| 2014 Q4 | 15.84 Billion JPY | -2.41% |
| 2014 Q2 | 19.25 Billion JPY | 4.8% |
| 2014 Q3 | 16.23 Billion JPY | -15.67% |
| 2014 FY | - JPY | -41.55% |
| 2013 Q2 | 38.48 Billion JPY | 43.18% |
| 2013 FY | - JPY | -4.84% |
| 2013 Q4 | 39.23 Billion JPY | 209.11% |
| 2013 Q3 | 12.69 Billion JPY | -67.02% |
| 2013 Q1 | 26.87 Billion JPY | -12.58% |
| 2012 Q3 | 32.04 Billion JPY | 4.11% |
| 2012 Q4 | 30.74 Billion JPY | -4.05% |
| 2012 Q1 | 31.74 Billion JPY | 21.19% |
| 2012 FY | - JPY | -13.94% |
| 2012 Q2 | 30.77 Billion JPY | -3.05% |
| 2011 Q4 | 26.19 Billion JPY | -40.73% |
| 2011 Q2 | 39.86 Billion JPY | 12.76% |
| 2011 FY | - JPY | -11.14% |
| 2011 Q1 | 35.35 Billion JPY | 109.52% |
| 2011 Q3 | 44.19 Billion JPY | 10.86% |
| 2010 Q1 | 45.52 Billion JPY | 190.38% |
| 2010 Q4 | 16.87 Billion JPY | -69.29% |
| 2010 FY | - JPY | 13.24% |
| 2010 Q3 | 54.94 Billion JPY | 18.09% |
| 2010 Q2 | 46.52 Billion JPY | 2.2% |
| 2009 Q3 | 51.1 Billion JPY | 33.23% |
| 2009 Q4 | 15.67 Billion JPY | -69.32% |
| 2009 FY | - JPY | -2.77% |
| 2009 Q1 | 39.58 Billion JPY | 20.62% |
| 2009 Q2 | 38.35 Billion JPY | -3.09% |
| 2008 Q3 | 39.23 Billion JPY | 6.71% |
| 2008 FY | - JPY | 175.87% |
| 2008 Q1 | 40.03 Billion JPY | 0.0% |
| 2008 Q2 | 36.76 Billion JPY | -8.17% |
| 2008 Q4 | 32.81 Billion JPY | -16.35% |
| 2007 FY | - JPY | -60.71% |
| 2006 FY | - JPY | 9.79% |
| 2005 FY | - JPY | 12.1% |
| 2004 FY | - JPY | 9.5% |
| 2003 FY | - JPY | 20.99% |
| 2002 FY | - JPY | -8.2% |
| 2001 FY | - JPY | 61.59% |
| 2000 FY | - JPY | 35.81% |
| 1999 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.02 Billion JPY | -1612.44% |
| Takeda Pharmaceutical Company Limited | 874.6 Billion JPY | 88.211% |
| Sumitomo Pharma Co., Ltd. | -281.07 Billion JPY | 136.683% |
| Shionogi & Co., Ltd. | 186.7 Billion JPY | 44.775% |
| Wakamoto Pharmaceutical Co.,Ltd. | 570.97 Million JPY | -17957.978% |
| Nippon Shinyaku Co., Ltd. | 36.29 Billion JPY | -184.117% |
| Kaken Pharmaceutical Co., Ltd. | 12.26 Billion JPY | -740.515% |
| Morishita Jintan Co., Ltd. | 1.29 Billion JPY | -7874.169% |
| Hisamitsu Pharmaceutical Co., Inc. | 18.34 Billion JPY | -462.192% |
| Mochida Pharmaceutical Co., Ltd. | 8.97 Billion JPY | -1049.069% |
| Fuso Pharmaceutical Industries,Ltd. | 3.67 Billion JPY | -2709.428% |
| Nippon Chemiphar Co., Ltd. | 1.4 Billion JPY | -7248.967% |
| Tsumura & Co. | 30.77 Billion JPY | -235.064% |
| Kissei Pharmaceutical Co., Ltd. | 18.72 Billion JPY | -450.78% |
| Torii Pharmaceutical Co., Ltd. | 5.27 Billion JPY | -1856.099% |
| Towa Pharmaceutical Co., Ltd. | 35.53 Billion JPY | -190.145% |
| Fuji Pharma Co., Ltd. | 6.88 Billion JPY | -1398.198% |
| Zeria Pharmaceutical Co., Ltd. | 17.52 Billion JPY | -488.449% |
| KYORIN Holdings, Inc. | 10.29 Billion JPY | -901.418% |
| Taiko Pharmaceutical Co.,Ltd. | -3.75 Billion JPY | 2849.493% |
| Daito Pharmaceutical Co.,Ltd. | 7.55 Billion JPY | -1265.1% |
| SymBio Pharmaceuticals Limited | -714 Million JPY | 14540.616% |
| MedRx Co., Ltd | -884.51 Million JPY | 11756.77% |
| Mizuho Medy Co.,Ltd. | 5.53 Billion JPY | -1762.366% |
| Solasia Pharma K.K. | -635 Million JPY | 16337.165% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 4443.275% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.16 Billion JPY | -1025.243% |
| Sawai Group Holdings Co., Ltd. | 36.87 Billion JPY | -179.625% |
| Cyfuse Biomedical K.K. | -538.28 Million JPY | 19254.395% |
| Toho Holdings Co., Ltd. | 25.84 Billion JPY | -298.94% |
| Koa Shoji Holdings Co.,Ltd. | 5.1 Billion JPY | -1921.036% |